newsfilter
← Latest News
GlobeNewswire·

Lexeo Therapeutics to Participate in the Chardan Healthcare Conference

  • Lexeo Therapeutics will participate in a fireside chat at Chardan's 10th Annual Healthcare Conference on October 20, 2026, at 9:30 am ET.
  • The event will be webcast live via the Investors section of the company's website, with a replay available afterward.
  • Lexeo Therapeutics is a New York City-based clinical stage company focused on treating cardiovascular & neurological genetic diseases.
  • The company is advancing therapeutic candidates including LX2006 for Friedreich ataxia & LX2020 for plakophilin-2 arrhythmogenic cardiomyopathy.
  • Media inquiries should be directed to Media@lexeotx.com, while investor inquiries should contact Ashley Kaplowitz at akaplowitz@lexeotx.com.